Shenzhen Mindray achieved the operation revenue of nearly CNY 11.2 billion in 2017, and became the first domestic medical devices enterprises with the operation revenue exceeding CNY ten billion in the industry. However, another medical devices enterprise at the level of ten billion is born after Mindray.
On April 28, SHINVA (SHINVA MEDICAL INSTRUMENT CO., LTD.), listed as A-share, published its annual report of 2017.
SHINVA achieved the operation revenue of CNY 9,983 million in 2017, representing an increase by 19.35% over the same period in 2016; achieved the total profit of CNY 283 million, representing a year-on-year increase by 38.87%; achieved the net profit of CNY 149 million, representing a year-on-year increase by 23.48%. The net profit attributed to shareholders of the listed company of CNY 65,528,700, representing a year-on-year increase by 89.19%.
SHINVA is an old state-owned enterprise in the industry with a relatively complicated business structure combining manufacture of medical devices, operation of drugs and devices, pharmaceutical equipment, as well as business in medical care area. Even so, the area of medical devices has been its absolute major business. Its medical devices include medical equipment for radiological diagnosis and treatment, medical sterilization equipment and test instruments as well as consumables.